Drugmaker Merck is fully exempting West Virginia covered entities from its 340B contract pharmacy restrictions, including all data submission requirements. [...] …
Year: 2024
Canadian drugmaker Bausch & Lomb announced last week that, beginning July 1, it will no longer offer 340B discounted products [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Irish drugmaker Alkermes will implement, on July 22, 340B contract pharmacy restrictions. The Dublin-based manufacturer is the 36th drugmaker to [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Michigan state lawmakers and representatives for drugmakers, providers, and business groups debated a 340B contract pharmacy access bill during a [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A major New York City hospital reported that decreased 340B pharmacy revenue helped drive millions in year-over-year losses in one [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A federal legislative overhaul of the 340B program could provide Medicare savings for the federal government, according to a review [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Five drugmakers have issued recent refund notices to 340B covered entities for drug overcharges. In letters posted on the website [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A House oversight hearing this week added to the growing debate over the 340B program’s future as federal lawmakers continue [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Minnesota became the 7th state to enact a law to protect distribution of 340B drugs through contract pharmacies when the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
New York lawmakers are expected to leave Albany this week without passing legislation that would bar drug manufacturers and pharmacy [...] …